Key Points
- Director Esteban Lopez sold 250 shares of Addus HomeCare at an average price of $93.00, totaling $23,250. After the transaction, he held 3,450 shares, a 6.76% reduction in his ownership.
- Addus HomeCare recently beat earnings expectations, reporting $1.62 EPS versus the $1.52 consensus estimate, while revenue rose 7.7% year over year to $363.5 million.
- Analyst sentiment remains mixed but positive overall, with a consensus rating of “Moderate Buy” and an average price target of $131.22, though some firms recently lowered their targets and issued cautious ratings.
Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) Director Esteban Lopez sold 250 shares of the stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $93.00, for a total value of $23,250.00. Following the completion of the transaction, the director directly owned 3,450 shares of the company's stock, valued at $320,850. This trade represents a 6.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Addus HomeCare Stock Performance
Shares of ADUS stock opened at $93.26 on Friday. Addus HomeCare Corporation has a 12-month low of $89.76 and a 12-month high of $124.43. The firm has a market capitalization of $1.74 billion, a price-to-earnings ratio of 17.24, a price-to-earnings-growth ratio of 1.29 and a beta of 0.92. The business has a 50 day simple moving average of $95.93 and a 200 day simple moving average of $105.56. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping analysts' consensus estimates of $1.52 by $0.10. The firm had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.42 earnings per share. On average, equities research analysts anticipate that Addus HomeCare Corporation will post 6.24 EPS for the current year.
Wall Street Analyst Weigh In
ADUS has been the subject of a number of research analyst reports. Stephens cut their target price on Addus HomeCare from $140.00 to $135.00 and set an "overweight" rating for the company in a research report on Wednesday, February 25th. KeyCorp restated an "overweight" rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Wall Street Zen downgraded Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research report on Saturday, March 21st. Citizens Jmp restated a "market outperform" rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Monday. Finally, Barclays cut their target price on Addus HomeCare from $102.00 to $92.00 and set an "underweight" rating for the company in a research report on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $131.22.
View Our Latest Report on ADUS
Institutional Investors Weigh In On Addus HomeCare
A number of institutional investors and hedge funds have recently modified their holdings of ADUS. Global Retirement Partners LLC lifted its holdings in shares of Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company's stock valued at $25,000 after purchasing an additional 186 shares in the last quarter. Larson Financial Group LLC increased its stake in shares of Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company's stock worth $28,000 after acquiring an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC acquired a new position in Addus HomeCare during the fourth quarter worth $29,000. Private Trust Co. NA increased its position in Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company's stock worth $30,000 after buying an additional 112 shares during the last quarter. Finally, Arax Advisory Partners increased its position in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company's stock worth $30,000 after buying an additional 137 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.
About Addus HomeCare
(
Get Free Report)
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.
The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
